What is the ideal mean arterial pressure (MAP) range for a myocardial infarction patient with an ejection fraction of 37% receiving norepinephrine infusion?

Ideal MAP Target for MI Patient with EF 37% on Norepinephrine

Target a MAP ≥ 65 mmHg initially, with strong consideration for higher targets (70-77 mmHg) given the reduced ejection fraction and likely elevated filling pressures in this cardiogenic shock scenario. 1

Primary Recommendation

The most recent high-quality guidelines (2025 ESICM) specifically recommend targeting an initial MAP of ≥ 65 mmHg in patients with cardiogenic shock 1. However, this represents a minimum threshold rather than an optimal target for your specific patient.

Why Higher Targets May Be Beneficial

In cardiogenic shock with reduced EF (37%), organ perfusion depends on the pressure gradient between MAP and elevated central venous pressure (CVP). When CVP is elevated—which is typical in heart failure and cardiogenic shock—a higher MAP target may be necessary to maintain adequate organ perfusion pressure 1.

Supporting Evidence:

• Recent observational data (2021) in cardiogenic shock patients showed that achieving MAP ≥ 70 mmHg was associated with significantly better outcomes:

  • Primary composite outcome: 42.2% vs 67.6% (adjusted RR 0.70) 2
  • All-cause mortality: 28.9% vs 57.8% (adjusted RR 0.56) 2

• The 2026 BOX-trial substudy in OHCA-related cardiogenic shock compared MAP targets of 63 vs 77 mmHg: While higher MAP increased cardiac index and SvO2, it also increased pulmonary capillary wedge pressure without improving mortality 3. This suggests a ceiling effect where excessive MAP elevation may worsen cardiac function.

Practical Algorithm

Start with MAP target of 65-70 mmHg, then individualize based on:

1. Clinical perfusion markers:

   • Lactate clearance (should normalize within 6 hours) 3
   • Urine output
   • Mental status
   • Skin perfusion

2. If perfusion remains inadequate at MAP 65-70 mmHg, consider increasing to 70-77 mmHg IF:

   • CVP is elevated (>12-15 mmHg)
   • Patient has history of chronic hypertension 1
   • Clinical improvement observed with higher pressures

3. Avoid excessive MAP targets (>77-80 mmHg) as this may:

   • Worsen left ventricular afterload in already failing heart
   • Increase pulmonary congestion 3
   • Require excessive norepinephrine doses with potential harm

Critical Considerations from AHA Guidelines

The 2021 AHA statement on MI-related cardiogenic shock emphasizes that norepinephrine is first-line therapy, targeting MAP >65 mmHg, but notes this target is not well-established and requires attentiveness to clinical perfusion status 4. The FDA labeling for norepinephrine recommends maintaining systolic BP 80-100 mmHg (roughly MAP 60-70 mmHg) 5.

Key Pitfalls to Avoid

• Don't rigidly adhere to MAP 65 mmHg if perfusion markers remain poor—this patient's reduced EF and likely elevated filling pressures may require higher targets 1, 2

• Monitor for excessive norepinephrine escalation—if requiring very high doses without achieving perfusion goals, consider mechanical circulatory support rather than further vasopressor escalation 4

• Ensure adequate volume status first—occult hypovolemia must be corrected before aggressive vasopressor titration 4, 5

• Watch for worsening pulmonary edema—excessive MAP targets may increase left ventricular afterload and pulmonary congestion in this patient with reduced EF 3

In summary: Begin with MAP 65-70 mmHg, titrate to 70-77 mmHg if needed based on perfusion markers and CVP, but avoid exceeding 77-80 mmHg given the risk of worsening cardiac function.